The Structural Bet the Labs Are Not Making
The convergence of AI leaders on healthcare carries an implicit claim: that model capability is the binding constraint on medical progress. The Stanford-Harvard report makes that claim harder to sustain. Clinical AI is already embedded in care at scale — the constraint is not the presence of AI tools but the architecture of the systems deploying them. A health organization that automates its existing triage workflow captures marginal gains; one that restructures around AI-enabled capacity models captures the transformation the lab CEOs are describing in their public statements. The labs are selling compression. The report is measuring friction. Those are different problems, and the labs that enter healthcare without acknowledging the second will find their platforms adopted without their outcomes being achieved.